Literature DB >> 24342635

Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model.

Nathalie M Vandevelde1, Paul M Tulkens, Françoise Van Bambeke.   

Abstract

Biofilms play a role in the pathogenicity of pneumococcal infections. A pharmacodynamic in vitro model of biofilm was developed that allows characterization of the activity of antibiotics against viability and biomass by using in parallel capsulated (ATCC 49619) and noncapsulated (R6) reference strains. Naive biofilms were obtained by incubating fresh planktonic cultures for 2 to 11 days in 96-well polystyrene plates. Induced biofilms were obtained using planktonic bacteria collected from the supernatant of 6-day-old naive biofilms. Biomass production was more rapid and intense in the induced model, but the levels were similar for both strains. Full concentration responses fitting sigmoidal regressions allowed calculation of maximal efficacies and relative potencies of drugs. All antibiotics tested (amoxicillin, clarithromycin, solithromycin, levofloxacin, and moxifloxacin) were more effective against young naive biofilms than against old or induced biofilms, except macrolides/ketolides, which were as effective at reducing viability in 2-day-old naive biofilms and in 11-day-old induced biofilms of R6. Macrolides/ketolides, however, were less potent than fluoroquinolones against R6 (approximately 5- to 20-fold-higher concentrations needed to reduction viability of 20%). However, at concentrations obtainable in epithelial lining fluid, the viabilities of mature or induced biofilms were reduced 15 to 45% (amoxicillin), 17 to 44% (macrolides/ketolides), and 12 to 64% (fluoroquinolones), and biomasses were reduced 5 to 45% (amoxicillin), 5 to 60% (macrolides/ketolides), and 10 to 76% (fluoroquinolones), with solithromycin and moxifloxacin being the most effective and the most potent agents (due to lower MICs) in their respective classes. This study allowed the ranking of antibiotics with respect to their potential effectiveness in biofilm-related infections, underlining the need to search for still more effective options.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24342635      PMCID: PMC3957900          DOI: 10.1128/AAC.01858-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  74 in total

1.  Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.

Authors:  Sven Hammerschmidt; Sonja Wolff; Andreas Hocke; Simone Rosseau; Ellruth Müller; Manfred Rohde
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone.

Authors:  L Drago; R Mattina; D Legnani; C L Romano; E Vianello; C Ricci; E De Vecchi
Journal:  Int J Immunopathol Pharmacol       Date:  2011 Oct-Dec       Impact factor: 3.219

3.  Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin.

Authors:  Gema del Prado; Vicente Ruiz; Plinio Naves; Violeta Rodríguez-Cerrato; Francisco Soriano; María del Carmen Ponte
Journal:  Diagn Microbiol Infect Dis       Date:  2010-08       Impact factor: 2.803

4.  The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms.

Authors:  Carlos J Sanchez; Pooja Shivshankar; Kim Stol; Samuel Trakhtenbroit; Paul M Sullam; Karin Sauer; Peter W M Hermans; Carlos J Orihuela
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

5.  Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance.

Authors:  Jenny Fernebro; Ingrid Andersson; Jack Sublett; Eva Morfeldt; Rodger Novak; Elaine Tuomanen; Staffan Normark; Birgitta Henriques Normark
Journal:  J Infect Dis       Date:  2003-12-30       Impact factor: 5.226

6.  A simple oral antimicrobial regimen effective in severe chronic bronchial suppuration associated with culturable Haemophilus influenzae.

Authors:  P J Cole; D E Roberts; S F Davies; R K Knight
Journal:  J Antimicrob Chemother       Date:  1983-02       Impact factor: 5.790

7.  The role of the biofilm matrix in structural development.

Authors:  N G Cogan; James P Keener
Journal:  Math Med Biol       Date:  2004-06       Impact factor: 1.854

Review 8.  What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).

Authors:  Donald E Low
Journal:  Infect Dis Clin North Am       Date:  2013-03       Impact factor: 5.982

9.  Streptococcus pneumoniae forms surface-attached communities in the middle ear of experimentally infected chinchillas.

Authors:  Sean D Reid; Wenzhou Hong; Kristin E Dew; Dana R Winn; Bing Pang; James Watt; David T Glover; Susan K Hollingshead; W Edward Swords
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

10.  The impact of the competence quorum sensing system on Streptococcus pneumoniae biofilms varies depending on the experimental model.

Authors:  Claudia Trappetti; Luciana Gualdi; Lorenzo Di Meola; Prashant Jain; Cindy C Korir; Paul Edmonds; Francesco Iannelli; Susanna Ricci; Gianni Pozzi; Marco R Oggioni
Journal:  BMC Microbiol       Date:  2011-04-14       Impact factor: 3.605

View more
  6 in total

Review 1.  Panel 4: Report of the Microbiology Panel.

Authors:  Stephen J Barenkamp; Tasnee Chonmaitree; Anders P Hakansson; Terho Heikkinen; Samantha King; Johanna Nokso-Koivisto; Laura A Novotny; Janak A Patel; Melinda Pettigrew; W Edward Swords
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

Review 2.  Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease.

Authors:  Yashuan Chao; Laura R Marks; Melinda M Pettigrew; Anders P Hakansson
Journal:  Front Cell Infect Microbiol       Date:  2015-01-13       Impact factor: 5.293

3.  In vivo virulence of Mycobacterium tuberculosis depends on a single homologue of the LytR-CpsA-Psr proteins.

Authors:  S Malm; S Maaß; U E Schaible; S Ehlers; S Niemann
Journal:  Sci Rep       Date:  2018-03-02       Impact factor: 4.379

4.  The Streptococcus pneumoniae pezAT Toxin-Antitoxin System Reduces β-Lactam Resistance and Genetic Competence.

Authors:  Wai T Chan; Manuel Espinosa
Journal:  Front Microbiol       Date:  2016-08-25       Impact factor: 5.640

5.  Evaluation of antimicrobial activity of chondrillasterol isolated from Vernonia adoensis (Asteraceae).

Authors:  Winnie Mozirandi; Dexter Tagwireyi; Stanley Mukanganyama
Journal:  BMC Complement Altern Med       Date:  2019-09-06       Impact factor: 3.659

6.  Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.

Authors:  Myriam V Valenzuela; Mirian Domenech; Patricia Mateos-Martínez; Fernando González-Camacho; Adela G de la Campa; Maria Teresa García
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.